• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Ventavis (iloprost) 10 mcg/mL inhalation solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- August 2009


Summary View



Information for Patients
  • Thus patients may want to adjust times of administration to cover planned activities. (Sentence added)